Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harmony Biosciences Holdings, Inc. - Common Stock (NQ:HRMY)

34.57 -2.45 (-6.62%)
Delayed Quote Updated: 2:12 PM EST, Nov 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Harmony Biosciences Holdings, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Harmony Biosciences Reports Third Quarter 2022 Financial Results and Business Updates
From Harmony Biosciences
Via GlobeNewswire
News headline image
Where Harmony Biosciences Stands With Analysts ↗
Analysts have provided the following ratings for Harmony Biosciences (NASDAQ:HRMY) within the last quarter: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Domino's Pizza To Rally 20%? Here Are 5 Other Price Target Changes For Friday ↗
Wedbush raised Domino's Pizza, Inc. (NYSE: DPZ) price target from $370 to $400. Wedbush analyst Nick Setyan maintained an Outperform rating on the stock. Domino's shares rose 10.4% to close at $333.26... 
Via Benzinga
News headline image
6 Analysts Have This to Say About Harmony Biosciences ↗
Harmony Biosciences (NASDAQ:HRMY) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Harmony Biosciences: Q1 Earnings Insights ↗
Harmony Biosciences (NASDAQ:HRMY) reported its Q1 earnings results on Tuesday, May 3, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review ↗
The Nasdaq and small caps rose while the S&P 500 is hitting resistance. 
Via Investor's Business Daily
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022 ↗
  
Via Benzinga
News headline image
Harmony Biosciences Makes Leap Out Of Buy Zone After Narcolepsy Drug Drives Beat ↗
Shares surged well above the 5% chase zone in early action Tuesday. 
Via Investor's Business Daily
News headline image
Harmony Biosciences: Q2 Earnings Insights ↗
  Harmony Biosciences (NASDAQ:HRMY) reported its Q2 earnings results on Tuesday, August 2, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
  
Via Benzinga
News headline image
Preview: Harmony Biosciences's Earnings ↗
Harmony Biosciences (NASDAQ:HRMY) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Harmony... 
Via Benzinga
News headline image
EXCLUSIVE: Has Biotech Bottomed? NYSE Executive Floor Director Says Biogen And These 3 Stocks Look Poised To Outperform ↗
Markets continue to trend lower amid rising inflation and Fed uncertainty, but one New York Stock Exchange floor director says the bottom may be in for a couple of beaten-down sectors. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Corcept Stock Near Buy Point; Strength Rating Jumps To 91 ↗
The new 91 RS Rating means that Corcept stock has outperformed 90% of all other stocks over the past year. 
Via Investor's Business Daily
News headline image
7 No-Brainer Biotech Stocks to Add to Your Buy List ↗
With the broader markets grumbling, investors should consider biotech stocks to buy for their permanently relevant profile. 
Via InvestorPlace
News headline image
80 Biggest Movers From Yesterday ↗
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume. XORTX Therapeutics Inc. (NASDAQ: XRTX) gained 59.1% to... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Harmony Biosciences Q1 2022 Earnings Conference Call On May 3, 2022 At 08:30 AM ET ↗
Harmony Biosciences (NASDAQ:HRMY) will host a conference call at 08:30 AM ET on May 3, 2022, to discuss Q1 2022 earnings results. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022 ↗
Upgrades 
Via Benzinga
News headline image
24 Biggest Movers From Yesterday ↗
Gainers Vertical Aerospace Ltd. (NYSE: EVTL) Shares hiked 30.93% to close at $9.82 on Tuesday after Deutsche Bank initiated coverage of the stock. Peabody Energy Corporation (... 
Via Benzinga
News headline image
Bristol Myers, Eli Lilly And 2 Others Prove You Can Still Make Money In Medical Stocks ↗
These four medical stocks are outperforming the lousy market for health care investors. 
Via Investor's Business Daily
News headline image
Harmony Biosciences: Q4 Earnings Insights ↗
Harmony Biosciences (NASDAQ:HRMY) reported its Q4 earnings results on Monday, February 28, 2022 at 07:30 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
News headline image
3 Desirable Drug Stocks With Very Promising Pipelines ↗
Drug makers with superb pipelines are likely to deliver great returns for long-term investors. Here are three drug stocks to consider. 
Via InvestorPlace
News headline image
Top Buzzing Stocks For 2022 ↗
Before making investment decisions, investors like me seek valuable insight on which sectors and/or which stocks will be giving high returns. Let’s have a broad look at what happened in 2021 and what’s... 
Via Talk Markets
News headline image
Datadog, Applied Materials Lead Five Stocks Near Buy Points For The New Year ↗
Your stocks to watch as 2022 starts include Datadog and chip Applied Materials. 
Via Investor's Business Daily
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2021 ↗
Upgrades Goldman Sachs upgraded the previous rating for Grupo Aeroportuario del Sureste SAB de CV 
Via Benzinga
News headline image
Harmony Biosciences Holdings, Inc. (HRMY) Q3 2021 Earnings Call Transcript ↗
HRMY earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2021 ↗
Upgrades According to B. Riley Securities, the prior rating for Monroe Capital Corp (NASDAQ: 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.